Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 263 results

Not applicableStudy completedNCT01549132
What this trial is testing

Retinal Oximtery Following Treatment for Diabetic Maculopathy

Who this might be right for
Diabetic Maculopathy
East Kent Hospitals University NHS Foundation Trust 45
Post-approval studies (Phase 4)Ended earlyNCT02570789
What this trial is testing

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 90
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Not applicableEnded earlyNCT00709657
What this trial is testing

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Who this might be right for
Macular DegenerationRegional Blood FlowVascular Endothelial Growth Factor
Medical University of Vienna 8
Early research (Phase 1)Study completedNCT00793975
What this trial is testing

Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 37
Not applicableNot Yet RecruitingNCT07368023
What this trial is testing

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Ningbo Medical Center Lihuili Hospital 300
Large-scale testing (Phase 3)Study completedNCT02033031
What this trial is testing

Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Medical University of Vienna 28
Testing effectiveness (Phase 2)UnknownNCT00809419
What this trial is testing

The NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

Who this might be right for
Age Related Macular Degeneration
NeoVista 32
Not applicableUnknownNCT05342857
What this trial is testing

Maximum Treatment Interval With Aflibercept T&E

Who this might be right for
Neovascular Age-related Macular Degeneration
Shin Kong Wu Ho-Su Memorial Hospital 100
Not applicableStudy completedNCT02310295
What this trial is testing

Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
University of Sao Paulo 45
Testing effectiveness (Phase 2)Looking for participantsNCT07049926
What this trial is testing

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 140
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Post-approval studies (Phase 4)Study completedNCT04411693
What this trial is testing

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
The Cleveland Clinic 23
Not applicableEnded earlyNCT01946399
What this trial is testing

Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF

Who this might be right for
Retinal Vein Occlusion (RVO)Macular Edema
Retina Research Institute, LLC 10
Testing effectiveness (Phase 2)Ended earlyNCT04999605
What this trial is testing

AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsRecurrent Ovarian CarcinomaRelapsed Ovarian Cancer+1 more
Akeso 8
Testing effectiveness (Phase 2)Study completedNCT00413829
What this trial is testing

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 20
Not applicableActive Not RecruitingNCT05607810
What this trial is testing

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Who this might be right for
Diabetic Macular EdemaDiabetic Retinopathy
Adverum Biotechnologies, Inc. 22
Post-approval studies (Phase 4)Study completedNCT02472366
What this trial is testing

A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy

Who this might be right for
Chronic Diabetic Macular Edema
Alimera Sciences 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Large-scale testing (Phase 3)UnknownNCT05297292
What this trial is testing

Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

Who this might be right for
Wet Age-related Macular Degeneration
Mabwell (Shanghai) Bioscience Co., Ltd. 433
Next Page